New EU medtech proposals: The political line up and potential stumbling blocks
This article was originally published in SRA
Executive Summary
There is a sense of urgency surrounding the European Commission's proposals to overhaul the regulatory framework for medical devices and in vitro diagnostics . If the proposals are not agreed by the European Parliament and Council and signed off by mid-2014, they could be delayed until well after the European Parliament elections taking place in June that year. But what is a realistic timeframe and who will influence it? Amanda Maxwell reports from the Association of British Healthcare Industries (ABHI) meeting on 17 October in London.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.